These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15187582)

  • 1. 'Compulsive' lever-pressing in rats is attenuated by the serotonin re-uptake inhibitors paroxetine and fluvoxamine but not by the tricyclic antidepressant desipramine or the anxiolytic diazepam.
    Joel D; Ben-Amir E; Doljansky J; Flaisher S
    Behav Pharmacol; 2004 May; 15(3):241-52. PubMed ID: 15187582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective alleviation of compulsive lever-pressing in rats by D1, but not D2, blockade: possible implications for the involvement of D1 receptors in obsessive-compulsive disorder.
    Joel D; Doljansky J
    Neuropsychopharmacology; 2003 Jan; 28(1):77-85. PubMed ID: 12496943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the striatum in compulsive behavior in intact and orbitofrontal-cortex-lesioned rats: possible involvement of the serotonergic system.
    Schilman EA; Klavir O; Winter C; Sohr R; Joel D
    Neuropsychopharmacology; 2010 Mar; 35(4):1026-39. PubMed ID: 20072118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strain differences in 'compulsive' lever-pressing.
    Brimberg L; Flaisher-Grinberg S; Schilman EA; Joel D
    Behav Brain Res; 2007 Apr; 179(1):141-51. PubMed ID: 17320982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excessive lever pressing following post-training signal attenuation in rats: a possible animal model of obsessive compulsive disorder?
    Joel D; Avisar A
    Behav Brain Res; 2001 Aug; 123(1):77-87. PubMed ID: 11377731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of 5-HT2A and 5-HT2C receptors in the signal attenuation rat model of obsessive-compulsive disorder.
    Flaisher-Grinberg S; Klavir O; Joel D
    Int J Neuropsychopharmacol; 2008 Sep; 11(6):811-25. PubMed ID: 18339223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal attenuation as a rat model of obsessive compulsive disorder.
    Goltseker K; Yankelevitch-Yahav R; Albelda NS; Joel D
    J Vis Exp; 2015 Jan; (95):52287. PubMed ID: 25650700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder.
    Woods A; Smith C; Szewczak M; Dunn RW; Cornfeldt M; Corbett R
    Psychopharmacology (Berl); 1993; 112(2-3):195-8. PubMed ID: 7871019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of selective serotonin reuptake inhibitors on immobility time in the tail suspension test in streptozotocin-induced diabetic mice.
    Kamei J; Miyata S; Morita K; Saitoh A; Takeda H
    Pharmacol Biochem Behav; 2003 May; 75(2):247-54. PubMed ID: 12873612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing anxiolytic-like effects of selective serotonin reuptake inhibitors and serotonin-noradrenaline reuptake inhibitors using the elevated plus maze in mice.
    Takeuchi T; Owa T; Nishino T; Kamei C
    Methods Find Exp Clin Pharmacol; 2010 Mar; 32(2):113-21. PubMed ID: 20401348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reinforcement magnitude modulates the rate-dependent effects of fluvoxamine and desipramine on fixed-interval responding in the pigeon.
    Lamb RJ; Ginsburg BC
    Behav Pharmacol; 2008 Feb; 19(1):51-60. PubMed ID: 18195594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reinforced spatial alternation as an animal model of obsessive-compulsive disorder (OCD): investigation of 5-HT2C and 5-HT1D receptor involvement in OCD pathophysiology.
    Tsaltas E; Kontis D; Chrysikakou S; Giannou H; Biba A; Pallidi S; Christodoulou A; Maillis A; Rabavilas A
    Biol Psychiatry; 2005 May; 57(10):1176-85. PubMed ID: 15866558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the orbital cortex and of the serotonergic system in a rat model of obsessive compulsive disorder.
    Joel D; Doljansky J; Roz N; Rehavi M
    Neuroscience; 2005; 130(1):25-36. PubMed ID: 15561422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential modulation of efficiency in a food-rewarded "differential reinforcement of low-rate" 72-s schedule in rats by norepinephrine and serotonin reuptake inhibitors.
    Dekeyne A; Gobert A; Auclair A; Girardon S; Millan MJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):156-67. PubMed ID: 12110993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of temporary inactivation of the orbital cortex in the signal attenuation rat model of obsessive compulsive disorder.
    Joel D; Klavir O
    Behav Neurosci; 2006 Aug; 120(4):976-83. PubMed ID: 16893303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of compulsive-like behavior by fluvoxamine in a non-induced mouse model of obsessive-compulsive disorder.
    Mitra S; Bult-Ito A
    Behav Pharmacol; 2018 Jun; 29(4):299-305. PubMed ID: 29035919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluvoxamine and desipramine on fixed-ratio responding: effects of reinforcement magnitude.
    Lamb RJ; Ginsburg BC
    Behav Pharmacol; 2005 Nov; 16(7):573-8. PubMed ID: 16170234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of desipramine and fluvoxamine on timing behavior investigated with the fixed-interval peak procedure and the interval bisection task.
    Ho MY; al-Zahrani SS; Velazquez Martinez DN; Lopez Cabrera M; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 1996 Jun; 125(3):274-84. PubMed ID: 8815964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of alprazolam and desipramine hydroxylation in vitro by paroxetine and fluvoxamine: comparison with other selective serotonin reuptake inhibitor antidepressants.
    von Moltke LL; Greenblatt DJ; Court MH; Duan SX; Harmatz JS; Shader RI
    J Clin Psychopharmacol; 1995 Apr; 15(2):125-31. PubMed ID: 7782485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of NMDA receptors in the signal attenuation rat model of obsessive-compulsive disorder.
    Albelda N; Bar-On N; Joel D
    Psychopharmacology (Berl); 2010 May; 210(1):13-24. PubMed ID: 20238210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.